8-K: Solitron Devices Reports Q1 Fiscal 2026 Net Loss Amidst Revenue Decline, Backlog Reaches Record High

Solitron Devices, Inc. announced a 32% decrease in net sales and a net loss of $0.34 million for its fiscal 2026 first quarter, despite a 94% increase in backlog to a record $18.26 million.

Summary

• Net sales decreased 32% to approximately $2.70 million in the fiscal 2026 first quarter, down from $3.97 million in the fiscal 2025 first quarter.
• Net bookings increased 37% to $2.80 million in the fiscal 2026 first quarter, compared to $2.04 million in the prior year first quarter.
• Backlog increased 94% to $18.26 million at the end of the fiscal 2026 first quarter, up from $9.41 million at the end of the fiscal 2025 first quarter, and also increased from $18.11 million at the beginning of the fiscal year.
• Net income was a loss of ($0.34) million, or ($0.16) per share, for the fiscal 2026 first quarter, a significant decline from net income of $0.59 million, or $0.28 per share, for the fiscal 2025 first quarter.
• The company invested $1.65 million for 6.4% of the units in CBE LLC, which purchased a 25% interest in CrossingBridge Advisors for $25.9 million.
• CrossingBridge Advisors reported its assets under management (AUM) were $4.0 billion as of June 30, 2025, an increase from $3.4 billion as of December 31, 2024.
• The U.S. Air Force requested an increase in AMRAAM production from 1,200 annually to 2,400 annually by 2028, a key defense program Solitron supplies.
• The company is actively pursuing new product development, including silicon carbide, and has developed various prototypes for customer testing.

Sentiment

Score: 4

Explanation: While the company reported a significant net loss and revenue decline, which are negative indicators, the record backlog and increased bookings provide a strong foundation for future revenue. Strategic investments and potential for increased defense program involvement (AMRAAM) offer positive long-term prospects. The current quarter's poor performance was somewhat anticipated by management, suggesting a temporary dip rather than a systemic issue.

Positives

• Net bookings increased 37% to $2.80 million in the fiscal 2026 first quarter, indicating strong new order intake.
• Backlog reached a record level, increasing 94% to $18.26 million at the end of the fiscal 2026 first quarter, providing future revenue visibility.
• The investment of $1.65 million in CBE LLC provides a royalty stream from CrossingBridge Advisors, which saw its assets under management grow to $4.0 billion.
• The U.S. Air Force's request to increase AMRAAM production from 1,200 to 2,400 annually by 2028 is positive news for a major defense program Solitron supplies.
• Increased interest in new product development, particularly silicon carbide, with prototypes already developed for potential customers, suggests future revenue diversification.

Negatives

• Net sales decreased significantly by 32% to $2.70 million in the fiscal 2026 first quarter compared to the prior year.
• The company reported a net loss of ($0.34) million, or ($0.16) per share, a substantial decline from a net income of $0.59 million in the prior year's first quarter.
• Cash and cash equivalents decreased from $4.099 million at February 28, 2025, to $2.570 million at May 31, 2025.
• Marketable securities decreased from $919 thousand to $659 thousand over the same period.

Risks

• Revenue continues to be impacted by the lag time between the receipt of orders and the production/fulfillment of those orders.
• Any requested increase in AMRAAM production requires Congressional approval, and there are no assurances that such approval will be granted.
• Potential adverse developments or changes in government budgetary spending and policy, including those related to the war in Ukraine, could affect the company.
• The possibility of reduced government spending on programs in which the company participates poses a risk.
• Inflation and elevated interest rates could negatively impact operations and financial performance.
• Adverse trends in the economy and the increased likelihood of a recession could affect demand for products.
• Management's estimates and assumptions regarding bookings, sales, and other metrics may prove to be incorrect.
• The timing and size of orders from clients, delivery schedules, and the company's liquidity and cash position are subject to variability.
• The ability to make appropriate adjustments to the cost structure is crucial for profitability.
• The ability to properly account for inventory in the future is a factor.
• Demand for products and the potential loss of, or reduction of business from, substantial clients could impact results.
• Dependence on government contracts carries risks, as these contracts are subject to termination, price renegotiations, and regulatory compliance.
• The ability to continue to integrate Micro Engineering Inc. (MEI) in an efficient and effective manner is ongoing.
• The MEI acquisition or any other acquisition or strategic transaction may not yield the desired or anticipated results or benefits.

Future Outlook

Management anticipates sales to pick up at the end of the fiscal second quarter and reach a steadier level in the fiscal third quarter. The company continues to be optimistic about creating additional revenue sources through increased interest in new product development, including silicon carbide. The potential for increased AMRAAM production by the U.S. Air Force, if approved by Congress, also presents a positive future opportunity.

Management Comments

• Revenue continued to be down in the first quarter, similar to the fourth quarter of fiscal year 2025, due to the lag time between receipt of orders and production/fulfillment of those orders.
• As previously noted in our last press release, we expected lower revenues in this quarter and anticipate sales to pick up at the end of the fiscal second quarter, before reaching a steadier level in the fiscal third quarter.
• On a positive note, the Company's backlog remains at record levels.
• While the request [for increased AMRAAM production] is positive news, any increase requires Congressional approval, and there are no assurances that approval will happen.
• We continue to see increased interest in new product development, including silicon carbide. We have developed various prototypes for testing by potential customers and continue to be optimistic about creating additional revenue sources.

Industry Context

Solitron Devices operates primarily within the military and aerospace sectors, manufacturing specialized semiconductor components. Its performance is closely tied to U.S. government defense spending and procurement cycles, as evidenced by its significant supply role in programs like AMRAAM. The mention of unfunded priorities lists (UPLs) highlights the political and budgetary influences on its core market. The company's diversification into a financial services investment via CBE LLC and its focus on silicon carbide development indicate efforts to broaden its revenue base and adapt to evolving technological demands within the broader semiconductor industry.

Comparison to Industry Standards

• The document does not provide specific comparable companies or industry benchmarks for direct financial performance comparison.
• The increase in CrossingBridge Advisors' AUM from $3.4 billion to $4.0 billion reflects growth within the asset management sector, but no specific industry average or competitor performance is provided for context.
• The U.S. Air Force's request to double AMRAAM production to 2,400 annually by 2028, if approved, would represent a significant increase in a key defense program, potentially positioning Solitron favorably within its niche.

Management Changes

Stakeholder Impact

• Shareholders: Experienced a net loss and decreased earnings per share, potentially impacting stock value in the short term. However, the record backlog and future growth prospects offer long-term potential.
• Employees: Continued high backlog and potential for increased defense program production could ensure stable employment and future workload.
• Customers: The company's ability to fulfill a record backlog and potential for increased production capacity for key programs like AMRAAM is positive for customers.
• Creditors: The decline in cash and net income could be a point of attention, but the balance sheet shows stable liabilities relative to assets.

Next Steps

• Anticipate sales to pick up at the end of the fiscal second quarter.
• Expect sales to reach a steadier level in the fiscal third quarter.
• Continue testing of silicon carbide prototypes by potential customers.
• Monitor Congressional approval process for the requested increase in AMRAAM production.

Key Dates

Recommendation

Keywords

Solitron Devices, SODI, semiconductor, military, aerospace, defense contracts, AMRAAM, silicon carbide, SEC filing, 8-K, quarterly results, net sales, net income, backlog, bookings, CBE LLC, CrossingBridge Advisors, unfunded priorities list